title: Persistent headache in patients with multiple sclerosis starting treatment with fingolimod.
authors.affiliation: MS Reference Center, Universidade Metropolitana de Santos, SP, Brazil.
authors.forename: Yara Dadalti
authors.initials: YD
authors.lastname: Fragoso
authors.forename: Tarso
authors.initials: T
authors.lastname: Adoni
authors.forename: Sidney
authors.initials: S
authors.lastname: Gomes
authors.forename: Marcus Vinicius Magno
authors.initials: MV
authors.lastname: Goncalves
authors.forename: Andre Palma da Cunha
authors.initials: AP
authors.lastname: Matta
authors.forename: Maria Fernanda
authors.initials: MF
authors.lastname: Mendes
authors.forename: Fabio
authors.initials: F
authors.lastname: Siquineli
mesh_terms: D000328:Adult; D005260:Female; D000068876:Fingolimod Hydrochloride / Q000009:adverse effects*; D006261:Headache / Q000139:chemically induced* / Q000175:diagnosis* / Q000453:epidemiology; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D009103:Multiple Sclerosis / Q000188:drug therapy* / Q000453:epidemiology; D013997:Time Factors; D016896:Treatment Outcome; D055815:Young Adult
chemical_list: D007166:Immunosuppressive Agents; D000068876:Fingolimod Hydrochloride